Published in Eur Heart J on April 01, 1982
Platelet size in myocardial infarction. Br Med J (Clin Res Ed) (1983) 1.38
Thrombosis and ischaemic heart disease. Br Heart J (1985) 0.81
Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease. Br J Clin Pharmacol (1983) 0.78
Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working Group. BMJ (1994) 9.91
The nature of endothelium-derived vascular relaxant factor. Nature (1984) 5.53
Factor 8 on the vascular intima: possible importance in haemostasis and thrombosis. Nat New Biol (1973) 2.43
Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest (1980) 2.41
Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol (1987) 2.30
Increased factor IX levels in puerperium during administration of diethylstilboestrol. Br Med J (1968) 2.29
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med (1990) 2.05
Allergic aspergillosis: review of 32 cases. Thorax (1968) 1.89
Adrenergic hypersensitivity after beta-blocker withdrawal. Br Heart J (1981) 1.87
Isolated perfused rabbit coronary artery and aortic strip preparations: the role of endothelium-derived relaxant factor. J Physiol (1984) 1.86
Nifedipine and left ventricular function in beta-blocked patients. Br Heart J (1981) 1.85
Patterns of use and incidence of smokeless tobacco consumption in school-age children. Arch Otolaryngol (1985) 1.80
Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency). Lancet (1984) 1.74
Acute haemodynamic effects of felodipine during beta blockade in patients with coronary artery disease. Br Heart J (1984) 1.74
Hyperinsulinaemia and microvascular angina ("syndrome X") Lancet (1991) 1.69
Pulmonary aspergillosis. A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests. Thorax (1968) 1.67
Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusion. Cardiovasc Res (1994) 1.63
Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation (1995) 1.57
Collapse after intravenous injection of hashish. Br Med J (1968) 1.46
Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol (1988) 1.45
Significance and interpretation of laboratory tests in pulmonary aspergillosis. J Clin Pathol (1967) 1.44
Reduced anisotropy of action potential conduction in left ventricular hypertrophy. J Cardiovasc Electrophysiol (2001) 1.43
In vivo EDRF activity influences platelet function. Br J Pharmacol (1988) 1.42
Haptoglobin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoid. Cardiovasc Res (1986) 1.42
Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) (1980) 1.41
Smokeless tobacco: the folklore and social history of snuffing, sneezing, dipping, and chewing. J Am Dent Assoc (1982) 1.40
Diagnosis of oesophageal spasm by ergometrine provocation. Gut (1982) 1.40
Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res (1970) 1.38
The apex beat. Ir Med J (1991) 1.38
Inherited variants of factor-VIII-related protein in von Willebrand's disease. N Engl J Med (1974) 1.36
Evidence that cyclic guanosine monophosphate (cGMP) mediates endothelium-dependent relaxation. Eur J Pharmacol (1985) 1.35
Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ (1996) 1.35
Dangers of amiodarone and anticoagulant treatment. Br Med J (Clin Res Ed) (1981) 1.35
Endothelial function is impaired in fit young adults of low birth weight. Cardiovasc Res (1998) 1.34
Production of endothelium derived relaxant factor is dependent on oxidative phosphorylation and extracellular calcium. Cardiovasc Res (1986) 1.33
Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin. Thorax (1968) 1.32
Postoperative problems and management after hepatic resection for blunt injury to the liver. Br J Surg (1975) 1.30
Myocardial mechanics in ppillary muscles of the rat and cat. Am J Physiol (1969) 1.30
Evidence that inhibitory factor extracted from bovine retractor penis is nitrite, whose acid-activated derivative is stabilized nitric oxide. Br J Pharmacol (1988) 1.29
Arrhythmias and cellular electrophysiological changes during myocardial "ischaemia" and reperfusion. Cardiovasc Res (1983) 1.26
Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations. Cardiovasc Res (1987) 1.25
Developing hospital-based domestic violence programs, protocols, policies, and procedures. AWHONNS Clin Issues Perinat Womens Health Nurs (1993) 1.22
Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population. J Assoc Physicians India (2002) 1.22
Influence of caffeine on force development and force-frequency relations in cat and rat heart muscle. Cardiovasc Res (1974) 1.22
Beta-blocker withdrawal syndrome. Lancet (1979) 1.20
Fibrin degradation products in pre-eclamptic toxaemia and eclampsia. Br Med J (1970) 1.20
The von Willebrand syndrome. Semin Hematol (1980) 1.19
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation (1989) 1.19
Stimulus-secretion coupling in vascular endothelial cells. Annu Rev Physiol (1990) 1.18
Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy. Circ Res (1997) 1.17
'Angina' and normal coronary arteriograms: a follow-up study. Eur Heart J (1980) 1.16
Mortality in acute upper gastrointestinal haemorrhage: a six-year survey from the University Hospital of Wales. Postgrad Med J (1981) 1.15
The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency. Br J Haematol (1975) 1.15
Malignant lymphoma presenting with a high eosinophilia, eosinophilic pleurisy, and pericrditis. Thorax (1969) 1.14
A clinical and experimental study of platelet function in chronic renal failure. J Clin Pathol (1972) 1.14
Facile and rapid analysis of three DNA polymorphisms within the human factor IX gene using the polymerase chain reaction. Br J Haematol (1991) 1.13
The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J (1994) 1.12
Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients. J Clin Invest (1987) 1.12
HTLV-III antibody status and immunological abnormalities in haemophilic patients. Lancet (1985) 1.12
Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med (1986) 1.12
Endothelium-derived relaxing factor and nitroprusside compared in noradrenaline- and K+-contracted rabbit and rat aortae. J Physiol (1988) 1.11
Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated effect. J Physiol (1986) 1.08
Epsilon-Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial. Br J Haematol (1971) 1.07
A phorbol ester inhibits the release of endothelium-derived relaxing factor. Eur J Pharmacol (1987) 1.06
Intravascular coagulation and the liver. Br J Haematol (1975) 1.04
The effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones. Br J Clin Pharmacol (1981) 1.04
High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol (1995) 1.03
Effects of 8-bromo-cyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol (1991) 1.03
Differences in basal endothelium-derived relaxing factor activity in different artery types. J Cardiovasc Pharmacol (1987) 1.02
Endothelium-derived relaxing factor. J Am Coll Cardiol (1988) 1.02
The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc Res (1999) 1.02
Differential localisation and synthesis of porcine factor VIII related antigen (VIIIR:AG) in vascular endothelium and in endothelial cells in culture. Thromb Res (1983) 1.02
Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol (1977) 1.00
The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities. Br J Haematol (1984) 1.00
Oesophageal spasm and angina: diagnostic value of ergometrine (ergonovine) provocation. Eur Heart J (1980) 1.00
Myocardial infarction with normal coronary arteries and factor XII deficiency. Br Heart J (1985) 0.99
Influence of endothelium on drug-induced relaxation of the rabbit aorta. Eur J Pharmacol (1986) 0.99
Unstimulated release of endothelium derived relaxing factor is independent of mitochondrial ATP generation. Cardiovasc Res (1987) 0.99
Endogenous prostaglandins, adenosine 3':5'-monophosphate and sodium transport across isolated frog skin. J Physiol (1976) 0.98
The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res (1995) 0.98
Changes in Blood After Using an Extracorporeal Circulation. Br Med J (1961) 0.97
Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine. J Clin Pathol (1965) 0.97
Carrier detection in 50 haemophilia A kindred by means of three intragenic and two extragenic restriction fragment length polymorphisms. Br J Haematol (1988) 0.97
A study of cell mediated and humoral immunity in haemophilia and related disorders. Br J Haematol (1985) 0.97
Tentative protocol for the evaluation of coagulometers, based on one-stage prothrombin time. Clin Lab Haematol (1981) 0.97
Coronary microangiography in the guinea pig, rabbit and ferret. Int J Cardiol (1984) 0.97
Linked and intragenic probes for haemophilia A. Lancet (1985) 0.96
Metabolic damage to human saphenous vein during preparation for coronary artery bypass grafting. Cardiovasc Res (1985) 0.96
Effect of tourniquet time on postoperative quadriceps function. Clin Orthop Relat Res (1979) 0.96
beta-Adrenoceptor hypersensitivity after stopping oxprenolol: discrepant findings not attributable to methodology. Br J Clin Pharmacol (1983) 0.96
Immunoradiometric assay of procoagulant factor-VIII antigen in plasma and serum and its reduction in haemophilia. Preliminary studies on adult and fetal blood. Lancet (1978) 0.96
Lichen myxoedematosus with associated cardiac abnormalities. Br J Dermatol (2001) 0.96
Depression of contractility in rat heart muscle by free fatty acids during hypoxia. Lancet (1969) 0.95